Alterations in corticotropin-releasing hormone gene expression of central amygdaloid neurons following long-term paraventricular lesions and adrenalectomy

Neuroscience

Volumn 85, Issue 1, 1998, Pages 135-147

  Palkovits, M ^a,b   Young III, W S ^b   Kovacs K ^c   Toth Zs ^a   Makara, G B ^c  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Adrenalectomy; Amygdala; CRH mRNA; In situ hybridization; Paraventricular nucleus; Phaseolus vulgaris leucoagglutinin

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; LEUKOAGGLUTININ; MESSENGER RNA;

ADRENALECTOMY; AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NEUROANATOMY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS;

ADRENALECTOMY; AMYGDALA; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; GENE EXPRESSION; IN SITU HYBRIDIZATION; MALE; NEURONS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PHYTOHEMAGGLUTININS; RATS; RATS, WISTAR; RNA, MESSENGER; SYNAPTIC TRANSMISSION; TIME FACTORS;

EID: 0031959981     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00621-0     Document Type: Article

References (53)

1. Beaulieu S., Pelletier G., Vaudry H., Barden N. Influence of the central nucleus of the amygdala on the content of corticotropin-releasing factor in the median eminence. Neuroendocrinology. 49:1989;255-261.
2. Beyer H. S., Matta S. G., Sharp B. M. Regulation of the messenger ribonucleic acid for corticotropin-releasing factor in the paraventricular nucleus and other brain sites of the rat. Endocrinology. 123:1988;2117-2123.
3. Britton K. T., Lee G., Dana R., Risch S. C., Koob G. F. Activating and "anxiogenic" effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone. Life Sci. 39:1986;1281-1286.
4. Cassell M. D., Gray T. S., Kiss J. Z. Neuronal architecture in the rat central nucleus of the amygdala: a cytological, hodological, and immunocytochemical study. J. comp. Neurol. 246:1986;478-499.
5. Cechetto D. F., Ciriello J., Calaresu F. R. Afferent connections to cardiovascular sites in the amygdala: a horseradish peroxidase study in the cat. J. auton. nerv. Syst. 8:1983;97-110.
6. Cintra A., Fuxe K., Solfrini V., Agnati L. F., Tinner B., Wiström A.-C., Staines W., Okret S., Gustafsson J.-A. Central peptidergic neurons as targets for glucocorticoid action: evidence for the presence of glucocorticoid immunoreactivity in various types of classes of peptidergic neurons. J. Steroid Biochem. molec. Biol. 40:1991;93-103.
7. Danielsen E. H., Magnuson D. J., Gray T. S. The central amygdaloid nucleus innervation of the dorsal vagal complex in rat: a Phaseolus vulgaris leucoagglutinin lectin anterograde tracing study. Brain Res. Bull. 22:1989;705-715.
8. Davis M. The role of the amygdala in fear and anxiety. A. Rev. Neurosci. 15:1992;353-375.
9. De Souza E. B., Insel T. R., Perrin M. H., Rivier J., Vale W. W., Kuhar M. J. Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J. Neurosci. 5:1985;3189-3203.
10. Elkabir D. R., Wyatt M. E., Vellucci S. V., Herbert J. The effects of separate or combined infusions of corticotrophin-releasing factor and vasopressin either intraventricularly or into the amygdala on aggressive and investigative behaviour in the rat. Regul. Pept. 28:1990;199-214.
11. Gerfen C., Sawchenko P. E. An anterograde neuroanatomical tracing method that shows the details of neurons, their axons and terminals: immunohistochemical localization of an axonally transported plant lectin, Phaseolus vulgaris leucoagglutinin (PHA-L). Brain Res. 290:1984;219-238.
12. Gray T. S. (1990) The organization and possible function of amygdaloid corticotropin-releasing factor pathways. In Corticotropin-releasing Factor: Basic and Clinical Studies of a Neuropeptide (eds De Souza E. and Nemeroff C. B.), pp. 53-68. CRC, Boca Raton, FL.
13. Gray T. S. (1991) Limbic pathways and neurotransmitters as modulators of autonomic and neuroendocrine responses to stress. The amygdala. In Stress: Neurobiology and Neuroendocrinology (eds Brown M. R., Koob G. F. and Rivier C.), pp. 73-89. Marcel Dekker, New York.
14. Gray T. S., Carney M. E., Magnuson D. J. Direct projections from the central amygdaloid nucleus to the hypothalamic paraventricular nucleus: possible role in stress-induced adrenocorticotropin release. Neuroendocrinology. 50:1989;433-446.
15. Hauger R. L., Millan M. A., Catt K. J., Aguilera G. Differential regulation of brain and pituitary corticotropin-releasing factor receptors by corticosterone. Endocrinology. 120:1987;1527-1533.
16. Hauger R. L., Irwin M. R., Lorang M., Aguilera G., Brown M. R. High intracerebral levels of CRH result in CRH receptor downregulation in the amygdala and neuroimmune desensitization. Brain Res. 616:1993;283-292.
17. Heinrichs S. C., Merlo Pich E., Miczek K. A., Britton K. T., Koob G. F. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res. 581:1992;190-197.
18. Honkainemi J., Pelto-Huikko M., Reckhardt L., Isola J., Lammi A., Fuxe K., Gustafsson J.-A., Wikström Å.-C., Hökfelt T. Colocalization of peptide and glucocorticoid receptor immunoreactivities in central amygdaloid nucleus. Neuroendocrinology. 55:1992;451-459.
19. Jingami H., Matsukara S., Numa S., Imura H. Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/β-lipotropin precursor mRNA in the pituitary in rats. Endocrinology. 117:1985;1314-1320.
20. Koegler-Muly S. M., Owens M. J., Ervin G. N., Kilts C. D., Nemeroff C. B. Potential corticotropin-releasing factor pathways in the rat brain as determined by bilateral electrolytic lesions of the central amygdaloid nucleus and the paraventricular nucleus of the hypothalamus. J. Neuroendocr. 5:1993;95-98.
21. Kovács K. J., Makara G. B. Corticosterone and dexamethasone act at different brain sites to inhibit adrenalectomy-induced adrenocorticotropin hypersecretion. Brain Res. 474:1988;205-210.
22. Lechan R. N., Nestler J. L., Jacobson S. The tuberoinfundibular system of the rat as demonstrated by immunohistochemical localization of retrogradely transported wheat germ agglutinin (WGA) from the median eminence. Brain Res. 245:1982;1-15.
23. Liang K. C., Lee E. H. Y. Intra-amygdala injections of corticotropin releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats. Psychopharmacology. 96:1988;232-236.
24. Liang K. C., Melia K. R., Campeau S., Falls W. A., Miserendino M. J. D., Davis M. Lesions of the central nucleus of the amygdala, but not the paraventricular nucleus of the hypothalamus, block the excitatory effects of corticotropin-releasing factor on the acoustic startle reflex. J. Neurosci. 12:1992;2313-2320.
25. Makara G. B., Stark E., Kapocs G., Antoni F. A. Long-term effects of hypothalamic paraventricular lesion on CRF content and stimulated ACTH secretion. Am. J. Physiol. 250:1986;E319-E324.
26. Makino S., Gold P. W., Schulkin J. Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res. 640:1994;105-112.
27. McDonald A. J. Cytoarchitecture of the central amygdaloid nucleus of the rat. J. comp. Neurol. 208:1982;401-418.
28. McDonald A. J. Projections of the intermediate subdivision of the central amygdaloid nucleus to the bed nucleus of the stria terminalis and medial diencephalon. Neurosci. Lett. 85:1988;285-290.
29. Merchenthaler I., Vigh S., Petrusz P., Schally A. V. The paraventriculo-infundibular corticotropin releasing factor (CRF) pathway as revealed by immunocytochemistry in long-term hypophysectomized or adrenalectomized rats. Regul. Pept. 5:1983;295-305.
30. Meyer J. S., Micco D. J., Stephenson B. S., Krey L. C., McEwen B. S. Subcutaneous implantation method for chronic glucocorticoid replacement therapy. Physiol. Behav. 22:1979;867-870.
31. Moga M. M., Gray T. S. Evidence for corticotropin-releasing factor, neurotensin, and somatostatin in the neural pathway from the central nucleus of the amygdala to the parabrachial nucleus. J. comp. Neurol. 241:1985;275-284.
32. Palkovits M., Kovács K., Makara G. B. Corticotropin-releasing hormone-containing neurons in the hypothalamo-hypophyseal system in rats six weeks after bilateral lesions of the paraventricular nucleus. Neuroscience. 42:1991;841-851.
33. Petrow T., Krukoff T. L., Jhamandas J. H. Branching projections of catecholaminergic brainstem neurons to the paraventricular hypothalamic nucleus and the central nucleus of the amygdala in the rat. Brain Res. 609:1993;81-92.
34. Rainnie D. G., Fernhout B. J. H., Shinnick-Gallagher P. Differential actions of corticotropin releasing factor on basolateral and central amygdaloid neurones, in vitro. J. Pharmac. exp. Ther. 263:1992;846-858.
35. Reul J. M. H. M., de Kloet E. R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology. 117:1985;2505-2511.
36. Sakanaka M., Shibasaki T., Lederis K. Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res. 382:1986;213-238.
37. Sawchenko P. E. Adrenalectomy-induced enhancement of CRF and vasopressin immunoreactivity in parvocellular neurosecretory neurons: anatomic, peptide, and steroid specificity. J. Neurosci. 7:1987;1093-1106.
38. Sawchenko P. E. and Swanson L. W. (1990) Organization of CRF immunoreactive cells and fibers in the rat brain: immunohistochemical studies. In Corticotropin-releasing Factor: Basic and Clinical Studies of a Neuropeptide (eds De Souza E. B. and Nemeroff C. B.), pp. 29-51. CRC, Boca Raton, FL.
39. Sun N., Roberts L., Cassell M. D. Rat central amygdaloid nucleus projections to the bed nucleus of the stria terminalis. Brain Res. Bull. 27:1991;651-662.
40. Swanson L. W., Simmons D. M. Corticosterone produces increased levels of CRF mRNA in the amygdala like it does neurotransmitter CRF cells in the PVN, while it produces major decreases in the neurohormonal cells in the parvicellular PVN. J. comp. Neurol. 285:1989;413-435.
41. Swiergiel A. H., Takahashi L. K., Kalin N. H. Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat. Brain Res. 623:1993;229-234.
42. Tannahill L. A., Sheward W. J., Robinson I. C. A. F., Fink G. Corticotropin-releasing factor-41, vasopressin and oxytocin release into hypophysial portal blood in the rat: effect of electrical stimulation of the hypothalamus, amygdala and hippocampus. J. Endocr. 129:1991;99-107.
43. ter Horst G. J., Luiten P. G. M. Phaseolus vulgaris leucoagglutinin tracing of intrahypothalamic connections of the lateral, ventromedial, dorsomedial and paraventricular hypothalamic nuclei in the rat. Brain Res. Bull. 18:1987;191-203.
44. Uryu K., Okumura T., Shibasaki T., Sakanaka M. Fine structure and possible origins of nerve fibers with corticotropin-releasing factor-like immunoreactivity in the rat central amygdaloid nucleus. Brain Res. 577:1992;175-179.
45. Van de Kar L. D., Piechowski R. A., Rittenhouse P. A., Gray T. S. Amygdaloid lesions: differential effect on conditioned stress and immobilization-induced increases in corticosterone and renin secretion. Neuroendocrinology. 54:1991;89-95.
46. Veening J. G., Swanson L. W., Sawchenko P. E. The organization of projections from the central nucleus of the amygdala to brainstem sites involved in central autonomic regulation: a combined retrograde transport-immunohistochemical study. Brain Res. 303:1984;337-357.
47. Volz H. P., Rehbein G., Triepel J., Knuepfer M. M., Stumpf H., Stock G. Afferent connections of the nucleus centralis amygdalae. A horseradish peroxidase study and literature survey. Anat. Embryol. 181:1990;177-194.
48. Wallace D. M., Magnuson D. J., Gray T. S. The amygdalo-brainstem pathway: selective innervation of dopaminergic, noradrenergic and adrenergic cells in the rat. Neurosci. Lett. 97:1989;252-258.
49. Wiegand S. J., Price J. L. Cells of origin of the afferent fibers to the median eminence in the rat. J. comp. Neurol. 192:1980;1-19.
50. Wiersma A., Bohus B., Koolhaas J. M. Corticotropin-releasing hormone microinfusion in the amygdala diminishes a cardiac parasympathetic outflow under stress-free conditions. Brain Res. 625:1993;219-227.
51. Wynn P. C., Hauger R. L., Holmes M. C., Millan M. A., Catt K. J., Aguilera G. Brain and pituitary receptors for corticotropin releasing factor: localization and differential regulation after adrenalectomy. Peptides. 5:1984;1077-1084.
52. Young W. S. III (1992) In situ hybridization with oligodeoxyribonucleotide probes. In In Situ Hybridization: A Practical Approach (ed. Wilkinson D. G.), pp. 33-44. FLR, Oxford.
53. Young W. S. III, Mezey E., Siegel R. E. Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats. Neurosci. Lett. 70:1986;198-203.